Cancer diagnostic company, Foundation Medicine, has announced that its stockholders approved each proposal in connection with the pending strategic transaction with Swiss drug maker Roche presented at the meeting held on April 2, 2015.
Around 80% of the total outstanding shares of common stock eligible to vote at the meeting were voted in favor of each proposal related to the Roche transaction.
Small Intestinal Cancer
Learn all about the early signs, symptoms, prevention and treatment of small intestine cancer.
Advertisement
The approval of these proposals satisfies one of the remaining closing conditions for the proposed transaction. The transaction with Roche includes the pending tender offer by Roche to purchase up to 15.6 million shares of Foundation Medicine common stock at a price of $50 per share, and the purchase by Roche of 5 million newly issued shares of Foundation Medicine common stock at a price of $50 per share.
The transaction with Swiss drug company also includes research & development and commercial collaborations between the parties. The pending transaction with the drug maker remains subject to the successful completion of the tender offer, which is scheduled to expire at the end of the day on Monday, April 6, 2015.
Subject to satisfaction or waiver of the remaining conditions to the transaction and closing of the Roche transaction is expected to occur on April 7, 2015.
Source: Medindia
Subject to satisfaction or waiver of the remaining conditions to the transaction and closing of the Roche transaction is expected to occur on April 7, 2015.
Source: Medindia
Squamous Cell Cancer of the Skin
Squamous cell cancer is the second most common type of skin cancer. White-skinned individuals exposed to excessive ultraviolet rays of the sun are commonly affected.
Advertisement
 Women and CancerCancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades. | Advertisement
|
AIDS-HIV-Cancer
AIDS defining malignancies are cancers that occur in patients with AIDS due to their low immunity.
Advertisement
Recommended Readings
Latest General Health News
In a tragic incident, a woman in the US experienced the loss of all her limbs as a result of a bacterial outbreak linked to the consumption of contaminated fish.
FluMos-v2, a unique universal influenza vaccine candidate, undergoing a phase 1 trial at NIH, increases recipients' immunity against many influenza viruses.
In Pakistan, the polio campaign focuses on more than 270,000 children under the age of five years, residing in areas with insufficient vaccine coverage.
Dangers of Wrong Diagnosis: Diagnostic errors in healthcare can increase the risk of permanent disabilities and deaths.
Due to our constant connectivity and the ability to be accessible at all times, it has become challenging to separate from work and fully participate in personal life.
